Using ctDNA Methylation to Monitor Metastatic Colorectal Cancer Treatment (PROMET)

NCT07283575 · clinicaltrials.gov ↗

RECRUITING

Status

497

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Colorectal Cancer ctDNA Surveillance

Interventions

DIAGNOSTIC_TEST: Plasma ctDNA methylation profiling

Sponsor

Fudan University